AiViva Biopharma, Inc.
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2016-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.aiviva.com
Effect of AIV007 by Periocular Administration in Subjects with Macular Edema Secondary to Neovascular Age-related Macular Degeneration (nAMD) and Diabetic Macular Edema (DME)
- Conditions
- Neovascular Age-related Macular DegenerationDiabetic Macular EdemaMacular Edema
- Interventions
- First Posted Date
- 2023-01-26
- Last Posted Date
- 2025-03-06
- Lead Sponsor
- AiViva BioPharma, Inc.
- Target Recruit Count
- 19
- Registration Number
- NCT05698329
- Locations
- 🇺🇸
Retina-Vitreous Associates, Beverly Hills, California, United States
🇺🇸Orange County Retina, Santa Ana, California, United States
🇺🇸Verum Research, Eugene, Oregon, United States
Safety and Efficacy of AIV001 on Scar Formation and Keloid Recurrence Following Keloidectomy
- First Posted Date
- 2021-04-01
- Last Posted Date
- 2024-12-27
- Lead Sponsor
- AiViva BioPharma, Inc.
- Target Recruit Count
- 25
- Registration Number
- NCT04827875
- Locations
- 🇺🇸
DermResearch DRI, Austin, Texas, United States
🇺🇸J&S Studies, College Station, Texas, United States
🇺🇸California Dermatology & Clinical Research Institute, Encinitas, California, United States
Safety and Efficacy Evaluation of AIV001 in Nonmelanoma Skin Cancer of the Low Risk Basal Cell Carcinoma Subtype
- Conditions
- Superficial Basal Cell CarcinomaNodular Basal Cell CarcinomaNonmelanoma Skin Cancers
- Interventions
- Drug: AIV001 suspension
- First Posted Date
- 2020-07-14
- Last Posted Date
- 2025-03-25
- Lead Sponsor
- AiViva BioPharma, Inc.
- Target Recruit Count
- 26
- Registration Number
- NCT04470726
- Locations
- 🇺🇸
Skin Surgery Medical Group, San Diego, California, United States
🇺🇸California Dermatology & Clinical Research Institute, Encinitas, California, United States
🇺🇸Island Dermatology, Newport Beach, California, United States
Effect of Intravitreally Administered AIV007 in Subjects With Neovascular Age-Related Macular Degeneration
- First Posted Date
- 2020-06-09
- Last Posted Date
- 2024-12-27
- Lead Sponsor
- AiViva BioPharma, Inc.
- Target Recruit Count
- 3
- Registration Number
- NCT04422899
- Locations
- 🇺🇸
Retina Research Institute of Texas, Abilene, Texas, United States
🇺🇸Salehi Retina Institute, Huntington Beach, California, United States
A Safety and Efficacy Study to Evaluate Rosacea
- First Posted Date
- 2019-03-21
- Last Posted Date
- 2024-12-17
- Lead Sponsor
- AiViva BioPharma, Inc.
- Registration Number
- NCT03883945
- Locations
- 🇺🇸
Cosmetic Laser Dermatology, San Diego, California, United States
A Safety and Efficacy Study to Evaluate AIV001 in Wound Healing Following Surgical Incision
- Conditions
- ScarIncisionAbdominalWound (Morphologic Abnormality)
- Interventions
- First Posted Date
- 2018-08-21
- Last Posted Date
- 2024-12-24
- Lead Sponsor
- AiViva BioPharma, Inc.
- Target Recruit Count
- 16
- Registration Number
- NCT03639883
- Locations
- 🇺🇸
Kaufman and Davis Plastic Surgery, Folsom, California, United States
🇺🇸Cosmetic Laser Dermatology, San Diego, California, United States